Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_assertion type Assertion NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_head.
- NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_assertion description "[Concentrations of TNF-? (median 15.0 vs. 25.1 pg/ml, area under the receiver operating characteristic curve [AUC] 0.91), IL-8 (48.7 vs. 103.3 pg/ml, AUC 0.85), IP-10 (176 vs. 566 pg/ml, AUC 0.83), MCP-1 (449 vs. 735 pg/ml, AUC 0.78), suPAR (3.5 vs. 5.2 ng/ml, AUC 0.78), MIG (100 vs. 152 pg/ml, AUC 0.75), and HGF (3.69 vs. 5.58 ng/ml, AUC 0.71) were significantly higher in patients with cirrhosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_provenance.
- NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_assertion evidence source_evidence_literature NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_provenance.
- NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_assertion SIO_000772 21229279 NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_provenance.
- NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_assertion wasDerivedFrom befree-2016 NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_provenance.
- NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_assertion wasGeneratedBy ECO_0000203 NP865050.RAIeiw1uCYvMm4YQMF_sZWKsELQRI6b3Xr7p06y8ExHgY130_provenance.